vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo ... will be priced at no more than $30 per vial and no more than $55 for a box of five pen ...

Sanofi SNY reported fourth-quarter 2024 adjusted earnings of 70 cents per American depositary share, which missed the Zacks ...

Eli Lilly announced at the beginning of March that it would reduce the price of its most commonly prescribed insulins by 70% in the US ... by 1,000% over the past 30 years. However, though ...

The balanced funds that have ticked (just about) all the boxes since 2022 ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales ...

France 30 Year Government Bond 0.0400 3.6872% ...

Lantus Combiflam Amaryl and Allegra feature in the top 100 pharmaceutical brands in India. The Company has its own manufacturing facility at Goa and ... Disclosure under Regulation 30 of SEBI (Listing ...

Now in its 16th year, Drapers 30 Under 30 celebrates the rising fashion retail stars and strongest talent who are bringing enthusiasm and creativity, exceptional drive and new ideas to the industry.